已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment

医学 血管性水肿 疾病 发病机制 免疫学 缓激肽 Icatibant公司 自身免疫 遗传性血管水肿 类胰蛋白酶 肥大细胞 受体 免疫系统 病理 内科学
作者
George Ν. Konstantinou,Marc A. Riedl,Peter Valent,Indrashis Podder,Marcus Maurer
出处
期刊:The Journal of Allergy and Clinical Immunology: In Practice [Elsevier BV]
卷期号:11 (1): 94-106 被引量:26
标识
DOI:10.1016/j.jaip.2022.11.006
摘要

Chronic spontaneous urticaria (CSU) is primarily a T2-dominant disease with a complex genetic background. Skin mast cell activation can be induced not only via the IgE-FcεRI axis but also from several other distinct mechanisms, molecules, and receptors involved in CSU onset, persistence, and exacerbation. These include autoallergy, autoimmunity, central or peripheral neuroimmune dysregulation, activation of both extrinsic and intrinsic coagulation pathways, and microbial infections. Besides mast cells, recent reports suggest the active and direct involvement of basophils and eosinophils. Several biological characteristics or biomarkers have been linked with CSU's known endotypes and may help forecast therapeutic responses. The introduction of biologic therapy for CSU has been a major advance in the last 10 years. The cornerstone of angioedema (AE) pathogenesis is increased vascular permeability and plasma leakage into the deeper dermis and subcutis, either mediated by histamine or bradykinin (BK). C1-inhibitor deficiency, hereditary or acquired, is the primary cause of BK-mediated AE due to increased plasma BK concentration. Other complex conditions have been identified, with some likely involving contact system dysregulation and other putative mechanisms related to vascular endothelial dysfunction. The approval of multiple hereditary-AE-specific therapies for both prevention and acute attacks has revolutionized treatment of this disease. Any new knowledge of the pathogenesis of CSU and AE offers the opportunity to improve patient information, physician-patient communication, prediction of therapeutic responses, selection of precise tailor-made treatment for each patient, and exploration of novel treatment options for those who do not achieve disease control with current medications. Chronic spontaneous urticaria (CSU) is primarily a T2-dominant disease with a complex genetic background. Skin mast cell activation can be induced not only via the IgE-FcεRI axis but also from several other distinct mechanisms, molecules, and receptors involved in CSU onset, persistence, and exacerbation. These include autoallergy, autoimmunity, central or peripheral neuroimmune dysregulation, activation of both extrinsic and intrinsic coagulation pathways, and microbial infections. Besides mast cells, recent reports suggest the active and direct involvement of basophils and eosinophils. Several biological characteristics or biomarkers have been linked with CSU's known endotypes and may help forecast therapeutic responses. The introduction of biologic therapy for CSU has been a major advance in the last 10 years. The cornerstone of angioedema (AE) pathogenesis is increased vascular permeability and plasma leakage into the deeper dermis and subcutis, either mediated by histamine or bradykinin (BK). C1-inhibitor deficiency, hereditary or acquired, is the primary cause of BK-mediated AE due to increased plasma BK concentration. Other complex conditions have been identified, with some likely involving contact system dysregulation and other putative mechanisms related to vascular endothelial dysfunction. The approval of multiple hereditary-AE-specific therapies for both prevention and acute attacks has revolutionized treatment of this disease. Any new knowledge of the pathogenesis of CSU and AE offers the opportunity to improve patient information, physician-patient communication, prediction of therapeutic responses, selection of precise tailor-made treatment for each patient, and exploration of novel treatment options for those who do not achieve disease control with current medications. What a Difference 10 Years Can MakeThe Journal of Allergy and Clinical Immunology: In PracticeVol. 11Issue 1PreviewThink back. What were you doing 10 years ago? It was 2013. The Baltimore Ravens won the Super Bowl, the World Baseball Classic was won by the undefeated Dominican Republic, Adam Scott was the first Australian to win the Masters, the Kentucky Derby winner was Orb, the Miami Heat secured the US National Basketball Association Finals, Chicago's Blackhawks won the Stanley Cup, Wimbledon singles winners were Andy Murray and Marion Bartoli, Chris Froome rode to the finish line first in the Tour de France, the Boston Red Sox hit it out of the park in the World Series, Bayern München prevailed in the FIFA World Cup,1 and, outside the world of sports, The Journal of Allergy and Clinical Immunology (JACI): In Practice published our inaugural issue. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
不灵0发布了新的文献求助10
4秒前
4秒前
5秒前
6秒前
7秒前
7秒前
8秒前
11完成签到,获得积分10
8秒前
jinlin发布了新的文献求助10
8秒前
9秒前
SYX发布了新的文献求助10
10秒前
10秒前
11秒前
徐徐发布了新的文献求助10
11秒前
长情语蕊发布了新的文献求助30
11秒前
lll完成签到,获得积分20
12秒前
12秒前
滴嘟完成签到,获得积分10
13秒前
13秒前
13秒前
上官若男的应助被汪进辉_Will采纳,获得10
13秒前
14秒前
Ebony完成签到,获得积分10
14秒前
16秒前
16秒前
17秒前
17秒前
彭于晏的应助被快乐的心情采纳,获得10
18秒前
SYX完成签到,获得积分10
18秒前
18秒前
xiezhihao发布了新的文献求助10
18秒前
传奇3的应助被滴嘟采纳,获得10
18秒前
zhhyi1976发布了新的文献求助10
19秒前
传奇3的应助被夏侯乌采纳,获得10
19秒前
浩懿一发布了新的文献求助10
21秒前
21秒前
圈圈发布了新的文献求助10
23秒前
过度干涉完成签到 ,获得积分10
23秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184619
求助须知:如何正确求助?哪些是违规求助? 9573576
关于积分的说明 21832380
捐赠科研通 7781845
什么是DOI,文献DOI怎么找? 3434399
关于科研通互助平台的介绍 2558498
邀请新用户注册赠送积分活动 2481003